新型コロナウイルス感染症の症状が確認された同居家族と接触した成人における、新型コロナウイルス感染症予防のための経口治療薬の可能性に関する研究

基本情報

NCT ID

NCT05047601

ステータス

完了

試験のフェーズ

第2/第3相

試験タイプ

介入

目標被験者数

2,954

治験依頼者名

Pfizer

概要

The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection. All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the experiences of people receiving the study medicines to those of the people who do not. This will help us determine if the study medicines are safe and effective

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)